User: Guest  Login
Title:

A single arm, multicentre, open-label phase II study of orally administered lapatinib (GW572016) as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma

Document type:
Meeting Abstract
Author(s):
Grimm, MO; Machiels, JP; Wülfing, C; Richel, D; Treiber, U; de Groot, M; Beuzeboc, P; Farrell, J; Colman, J; El-Hariry, I
Journal title abbreviation:
Ann Oncol
Year:
2005
Journal volume:
16 Suppl.
Pages contribution:
41-41
Language:
eng
Print-ISSN:
0923-7534
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX